Clinical Trials Browser

Phase 2 × Lung Neoplasms × SHR-1701 × Clear all

NCT04884009 2021-05-12

A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Unknown

Lung Neoplasms